Standardized Extract of Mangifera Indica L. Leaves as an Antimycobacterial and Immunomodulatory Agent

groupview

Abstract
Pharmacognosy Communications,2016,6,3,137-147.
Published:March 2016
Type:Original Article

Standardized Extract of Mangifera Indica L. Leaves as an Antimycobacterial and Immunomodulatory Agent

Sunita Shailajan1*, Sasikumar Menon2, Savita Kulkarni3, Bhavesh Tiwari1

1Department of Botany, Herbal Research Laboratory, Ramnarain Ruia College, Mumbai, INDIA.

2Institute for Advanced Training and Research in Interdisciplinary Sciences (TDM Laboratory), Mumbai, INDIA.

3Radiation Medicine Centre, Bio-Medical Group, Bhabha Atomic Research Centre, Mumbai, INDIA.

Abstract:

Background: Mangifera indica L.; the largest fruit-tree found in India, is an important component of indigenous medical systems. Mangifera indica L. leaves (MIL) have been reported to possess various biological activities and thus, can be a useful source of substances for drug development. Although the leaves have been traditionally used as antibacterial and immunomodulatory agent, there is a paucity of scientific data in support of their efficacy. The purpose of this study was an in-depth evaluation of antimycobacterial and immunomodulatory activity of a standardized extract of MIL. Material and methods: The hexane extract of Mangifera indica L. leaves (HEMIL) was prepared and standardized. Chromatographic characterization of HEMIL was done using validated HPLC and GC-MS/MS technique. HEMIL was evaluated for antimycobacterial and immunomodulatory activity by using various in vitro and in vivo assays. Results and discussion: HEMIL showed lupeol and stigmasterol content of 21.04 ± 0.03 mg/g and 16.99 ± 0.04 mg/g, respectively; and total terpenoids content of 112.55 ± 2.16 mg LE/g. GC-MS/MS characterization of the extract confirmed the presence of lupeol and stigmasterol and revealed five other phytochemical constituents. The safety of HEMIL was established in vitro and in vivo. HEMIL showed concentration-dependent inhibition of MTB as evident in REMA and radiorespirometry. HEMIL was also found efficacious in immunomodulatory evaluations using RAW 264.7 cells, human PBMCs, cyclophosphamide induced myelosuppressed mice and SRBCs stimulated mice. Conclusion: The promising results not only support the traditional claim of MIL as antibacterial and immunomodulatory agent but also provide data on their use in food supplements for immuno-pharmacological use.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.